Sanofi lands 3rd Covid-19 vaccine manufacturing partner as it works to push forward its own jab
As the demand for mRNA-based Covid-19 vaccines persists, Sanofi is jumping into the fray.
The French drugmaker has entered an agreement with Moderna to manufacture the company’s Covid-19 vaccine. The agreement marks the third different company Sanofi has paired with to manufacture a Covid-19 vaccine, since their own effort to develop a pandemic inoculation faced significant setbacks.
The company will perform fill-and-finish at its Ridgefield, NJ site to complete up to 200 million doses of the vaccine. That will begin in September.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.